Kurs Repros Therapeutics Inc

Aktien

26.01.18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15.12.17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12.12.17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12.12.17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12.12.17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	Perf. 1 Jahr	Perf. 3 Jahre	Marktkap.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	-0.68%	+3.03%	+9.79%	+37.65%	48.85 Mrd.
IQVIA HOLDINGS INC.	-0.73%	-0.41%	+48.84%	+36.72%	44.28 Mrd.
REVOLUTION MEDICINES, INC.	+1.36%	+6.03%	+343.85%	+638.73%	43.83 Mrd.
BEONE MEDICINES AG	-0.47%	-0.76%	+9.75%	+103.07%	41.53 Mrd.
CELLTRION, INC.	+0.34%	+0.22%	+5.18%	+47.36%	30.13 Mrd.
MEDPACE HOLDINGS, INC.	+1.00%	-1.28%	+24.23%	+156.93%	17.36 Mrd.
EUROFINS SCIENTIFIC SE	-1.15%	-1.08%	+21.95%	+43.94%	14.99 Mrd.
TEMPUS AI, INC.	-2.94%	+6.98%	+5.10%	-	14.9 Mrd.
ASCENDIS PHARMA A/S	-0.86%	-4.00%	-	-	14.98 Mrd.
Durchschnitt	-0.20%	+0.61%	+58.59%	+152.06%	30.09 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt	-0.17%	+1.21%	+74.64%	+168.28%

Beschäftigte

Sektor